Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (211)
  • 2024 (225)
  • 2023 (239)
  • 2022 (190)
  • 2021 (97)
  • 2020 (15)
  • 2019 (20)
  • 2018 (5)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4013)
  • Synthetic drugs (1065)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Arrests/Convictions - Major (604)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (457)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (6)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Fake Pills (655)
  • Prescription Drugs (364)

Drug Name

  • Fentanyl (576)
  • Methamphetamine (258)
  • Cocaine (119)
  • Heroin (106)
  • Oxycodone (103)
  • Opioids (65)
  • Synthetic Opioids (52)
  • Marijuana (Cannabis) (23)
  • Hydromorphone (19)
  • Benzodiazepines (13)
  • Morphine (10)
  • Amphetamines (9)
  • Ecstasy/MDMA (7)
  • Methadone (7)
  • Ketamine (3)
  • Steroids (3)
  • LSD (2)
  • Psilocybin (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • Seattle (224)
  • New England (130)
  • Washington, DC (92)
  • St. Louis (75)
  • New York (46)
  • El Paso (45)
  • Houston (43)
  • Miami (33)
  • Atlanta (31)
  • Sede (31)
  • Chicago (29)
  • Dallas (29)
  • Phoenix (27)
  • Omaha (26)
  • Rocky Mountain (25)
  • San Francisco (25)
  • New Jersey (23)
  • Los Angeles (20)
  • Louisville (20)
  • San Diego (15)
  • New Orleans (12)
  • Detroit (3)
  • Philadelphia (2)
Clear All Results
PRESS RELEASE

Drug Enforcement Administration Announces the Seizure of Over 379 Million Deadly Doses of Fentanyl in 2022

Diciembre 21, 2022
MIAMI – As 2022 comes to an end, the Drug Enforcement Administration (DEA) is announcing the seizure of over 50.6 million fentanyl-laced, fake prescription pills and more than 10,000 pounds of fentanyl powder this calendar year. The DEA Laboratory estimates that these seizures represent more than 379 million potentially deadly...
Diciembre 21, 2022
PRESS RELEASE

Drug Enforcement Administration Announces the Seizure of Over 379 million Deadly Doses of Fentanyl in 2022

Diciembre 20, 2022
WASHINGTON – As 2022 comes to an end, the Drug Enforcement Administration is announcing the seizure of over 50.6 million fentanyl-laced, fake prescription pills and more than 10,000 pounds of fentanyl powder this calendar year. The DEA Laboratory estimates that these seizures represent more than 379 million potentially deadly doses...
Diciembre 20, 2022
PRESS RELEASE

Butte Drug Trafficking Organization with Ties to the Sinaloa Cartel Dismantled

Diciembre 16, 2022
BUTTE, Mont. — A multi-agency investigation into a drug trafficking organization with ties to the Sinaloa Cartel, which brought massive quantities of methamphetamine, counterfeit oxycodone pills containing fentanyl and heroin to Butte for redistribution, has resulted in the federal convictions of 22 people. U.S. Attorney Jesse Laslovich hosted a press...
Diciembre 16, 2022
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

Diciembre 15, 2022
WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
Diciembre 15, 2022
PRESS RELEASE

Young Laredoan Admits to Transporting Fentanyl Disguised as Oxycodone

Diciembre 14, 2022
LAREDO, Texas A 19year-old Laredo resident has entered a guilty plea to transporting approximately 1.42 kilograms of fentanyl, announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux, Houston Division and U.S. Attorney Alamdar S. Hamdani. Ivan Eleodoro Garcia admitted that on Sept. 29, he was driving a...
Diciembre 14, 2022
PRESS RELEASE

Kansas Pharmacy Agrees to Pay $3 Million for Improperly Dispensing Meds

Diciembre 13, 2022
KANSAS CITY, Kan. - PharmScript of KS, LLC, a long-term care pharmacy in Lenexa, Kansas, has agreed to pay $3 million to resolve allegations that it violated federal law by dispensing controlled substances to residents in nursing and long-term care facilities without valid prescriptions and that the company was wrongfully...
Diciembre 13, 2022
PRESS RELEASE

Spanaway, Washington Man Sentenced to Eight Years in Prison for Key Role in Drug Distribution Ring

Diciembre 13, 2022
Seattle – A 61-year-old Spanaway, Washington man was sentenced today in U.S. District Court in Seattle to eight years in prison for his key role in a large drug distribution ring, announced U.S. Attorney Nick Brown. Dwayne Douglas George was indicted in November 2021, along with 16 other defendants. George...
Diciembre 13, 2022
PRESS RELEASE

Miami Woman Arrested on Fentanyl Charge Following Traffic Stop in Jamestown

Diciembre 13, 2022
BUFFALO, N.Y. – U.S. Attorney Trini E. Ross and Frank A. Tarentino III, Special Agent in Charge, New York Division, Drug Enforcement Administration (DEA) announced today that Elina Martinez, 64, of Miami, FL, was arrested and charged by criminal complaint with possession with intent to distribute, and distribute, 400 grams...
Diciembre 13, 2022
PRESS RELEASE

Doctor and Eight Others Charged with Distributing Opioids and Other Pills

Diciembre 09, 2022
MANHATTAN – Manhattan District Attorney Alvin L. Bragg, Jr., today announced the indictments of nine individuals, including Tribeca physician Dr. Noel Smith, for charges including conspiring to distribute tens of thousands of prescription pills, including opioids and other controlled substances, in Manhattan and Staten Island. The defendants allegedly operated a...
Diciembre 09, 2022
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

Diciembre 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
Diciembre 07, 2022
Showing 681 - 690 of 1006 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 65
  • Página 66
  • Página 67
  • Página 68
  • Current page 69
  • Página 70
  • Página 71
  • Página 72
  • Página 73
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster